Lv1
86 积分 2024-08-09 加入
Statistical analysis of the unique characteristics of secondary structures in proteins
2个月前
已完结
Isoalantolactone targets NLRP3 to disrupt NLRP3-NEK7 interaction and suppress inflammasome activation
2个月前
已完结
Targeted Degradation of Mutant p53 Reverses the Pro-oncogenic Dominant-Negative Effect
2个月前
已完结
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors
2个月前
已完结
Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development
2个月前
已完结
A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignancies
2个月前
已完结
Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development
2个月前
已完结
CD137 deficiency patients: two new patients and review of the literature
2个月前
已关闭
The biology of VSIG4: Implications for the treatment of immune-mediated inflammatory diseases and cancer
2个月前
已完结
Crystal structure of beta-catenin and the MDM2 p53-binding domain in complex with H333, a Helicon Polypeptide
3个月前
已关闭
皖公网安备34019202002308
